The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Promoting Hepatic Regeneration - EP3352768

The patent EP3352768 was granted to Intercept Pharmaceuticals on Nov 2, 2022. The application was filed on Sep 21, 2016 under application number EP16849506A. The patent is currently recorded with a legal status of "Revoked".

EP3352768

INTERCEPT PHARMACEUTICALS
Application Number
EP16849506A
Filing Date
Sep 21, 2016
Status
Revoked
May 17, 2024
Publication Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZAug 1, 2023KRAUS & LEDERER PARTGMBBADMISSIBLE
HAMM & WITTKOPPJul 27, 2023HAMM & WITTKOPPADMISSIBLE
TEVA PHARMACEUTICALSJul 25, 2023VON KAUFFMANNADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2014057886
DESCRIPTIONUS2014371190
DESCRIPTIONUS7786102
DESCRIPTIONUS7932244
DESCRIPTIONUS7994352
DESCRIPTIONWO2008002573
INTERNATIONAL-SEARCH-REPORTUS2014057886
INTERNATIONAL-SEARCH-REPORTUS2014206657
INTERNATIONAL-SEARCH-REPORTUS2014371190
INTERNATIONAL-SEARCH-REPORTWO2015075557
OPPOSITIONEP1392714
OPPOSITIONUS2014371190
OPPOSITIONWO02072598
SEARCHWO2008002573

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents